Filing Flows › Kewaunee Scientific (KEQU) › Q4 FY25
Kewaunee Scientific (KEQU) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Jul 2, 2025
Kewaunee Scientific (KEQU) reported revenue of $77.1M for the fourth quarter fiscal 2025 (Q4 FY25), +36% from a year earlier and +15% from the quarter before. Operating margin was 11.0%, net earnings $4.8M (6.3% of revenue).
Kewaunee Scientific, Q4 FY25: revenue $77.1M (+36% year over year), operating margin 11.0%, net earnings $4.8M, operating cash flow $9.4M. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $77.1M | +15% | +36% |
| Gross profit | $24.0M | +31% | +64% |
| Operating profit | $8.5M | +278% | +53% |
| Net earnings | $4.8M | +258% | -56% |
| Operating cash flow | $9.4M | — | +722% |
| Free cash flow | $8.9M | — | 54× |
What changed
Revenue was $77.1M in Q4 FY25, up 36% year over year and up 15% from the previous quarter.
Gross margin was 31.2%, up 5.3 points from a year earlier. Operating profit was $8.5M, a 11.0% margin (up 1.2 points year over year). Of the extra revenue versus a year earlier, 14% reached operating profit, above the 10% margin then. Operating expenses grew 71% against revenue growth of 36%. Net earnings were $4.8M, down 56% year over year. The effective tax rate was 30.8%.
Operating cash flow was $9.4M (up 722% year over year), 190% of net earnings. Non-cash charges added back $1.6M of depreciation and amortization and $370K of share-based compensation. Working capital and other items added $2.5M. Capital expenditures of $516K left free cash flow of $8.9M.
Questions
What was Kewaunee Scientific's revenue in the fourth quarter fiscal 2025?
Kewaunee Scientific (KEQU) reported revenue of $77.1M for the fourth quarter fiscal 2025 (Q4 FY25), +36% from a year earlier and +15% from the quarter before.
Was Kewaunee Scientific profitable in the fourth quarter fiscal 2025?
Operating profit was $8.5M (11.0% of revenue) and net earnings $4.8M.